Former New Zealand prime minister John Key has three white rabbits painted on his helicopter, a nod to his “massively superstitious” habit of repeating “white rabbits” three times at the start of every month. Tennis…
Read More
By Nia Williams (Reuters) -Canadian Prime Minister Justin Trudeau on Saturday condemned violence and antisemitism at anti-NATO and pro-Palestinian protests in downtown Montreal on Friday night, where NATO delegates have gathered for the alliance’s annual…
Read More
Rockets aren’t the only thing Elon Musk is sending into the stratosphere. After a three-year plummet, Dogecoin is blasting off again, jumping 250% since the election of Donald Trump – part of a broader wave…
Read More
These technologies enable the identification and swift resolution of emerging issues, as well as preventative action Key findings Just over half of the 15 respondents are using regtech and suptech. One central bank is currently implementing…
Read More
Water is ubiquitous on Earth – about 70% of Earth’s surface is covered by the stuff. Water is in the air, on the surface and inside rocks. Geologic evidence suggests water has been stable on…
Read More
By Valerie Volcovici BAKU, Azerbaijan (Reuters) – Russia has included the territories it occupies in Ukraine in its recent greenhouse gas inventory report to the United Nations, drawing protests from Ukrainian officials and activists at…
Read More
The U.S. House of Representatives has passed a bill that would empower the Treasury Department to eliminate the tax-exempt status of any nonprofit it deems to be supporting terrorism. The Stop Terror-Financing and Tax Penalties…
Read More
By Scott DiSavino (Reuters) -Oil prices climbed about 1% on Friday, settling at a two-week high, as the intensifying war in Ukraine this week boosted the market’s geopolitical risk premium. () futures rose 94 cents,…
Read More
OpenAI, the tech company that created the popular ChatGPT chatbot, is at a crossroads. It began as a nonprofit dedicated to developing artificial intelligence systems smarter than humans. Since its founding, OpenAI has boasted that…
Read More
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision…
Read More